FGFR1 and neoplasm: PD173074 is a potent inhibitor of FGFR1 and VEGFR2, showing inhibitory effects on TNBC in both in vitro and in vivo assays, as well as anti-tumour activity in FGFR-amplified TNBC cell lines (60, 61).